Biohit Oyj (HEL:BIOBV)
Finland
· Delayed Price · Currency is EUR 3.070
+0.190 (6.60%)
Feb 21, 2025, 6:29 PM EET
Biohit Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 14.3 | 13.08 | 10.95 | 9.36 | 7.12 | Upgrade
|
| Revenue Growth (YoY) | 9.36% | 19.40% | 16.99% | 31.42% | -29.14% | Upgrade
|
| Cost of Revenue | 5 | 4.61 | 3.84 | 3.45 | 3.17 | Upgrade
|
| Gross Profit | 9.3 | 8.46 | 7.11 | 5.92 | 3.96 | Upgrade
|
| Selling, General & Admin | 4 | 4.09 | 3.63 | 3.45 | 3.06 | Upgrade
|
| Other Operating Expenses | 2.4 | 2.19 | 1.87 | 1.98 | 2.07 | Upgrade
|
| Operating Expenses | 6.7 | 6.64 | 5.98 | 7.42 | 7.13 | Upgrade
|
| Operating Income | 2.6 | 1.83 | 1.13 | -1.5 | -3.17 | Upgrade
|
| Interest Expense | -0.3 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.6 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.03 | -0.01 | 0.02 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.41 | -0.29 | 0.09 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | 2.9 | 2.26 | 0.83 | -1.39 | -3.34 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.07 | 0.04 | 0.06 | 0.08 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.02 | - | Upgrade
|
| Pretax Income | 2.9 | 2.2 | 0.87 | -1.31 | -3.26 | Upgrade
|
| Income Tax Expense | 0.3 | 0.34 | 0.27 | 0.2 | 0.05 | Upgrade
|
| Earnings From Continuing Operations | 2.6 | 1.85 | 0.6 | -1.5 | -3.31 | Upgrade
|
| Net Income | 2.6 | 1.85 | 0.6 | -1.5 | -3.31 | Upgrade
|
| Net Income to Common | 2.6 | 1.85 | 0.6 | -1.5 | -3.31 | Upgrade
|
| Net Income Growth | 40.46% | 207.99% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 1.10% | 0.41% | 0.13% | - | 0.27% | Upgrade
|
| EPS (Basic) | 0.17 | 0.12 | 0.04 | -0.10 | -0.22 | Upgrade
|
| EPS (Diluted) | 0.17 | 0.12 | 0.04 | -0.10 | -0.22 | Upgrade
|
| EPS Growth | 41.67% | 200.41% | - | - | - | Upgrade
|
| Free Cash Flow | 0.2 | 0.65 | 1.79 | -0.48 | -0.04 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.04 | 0.12 | -0.03 | -0.00 | Upgrade
|
| Gross Margin | 65.03% | 64.73% | 64.94% | 63.19% | 55.57% | Upgrade
|
| Operating Margin | 18.18% | 13.96% | 10.30% | -16.02% | -44.56% | Upgrade
|
| Profit Margin | 18.18% | 14.16% | 5.49% | -16.02% | -46.51% | Upgrade
|
| Free Cash Flow Margin | 1.40% | 5.00% | 16.34% | -5.10% | -0.56% | Upgrade
|
| EBITDA | 2.9 | 1.93 | 1.34 | 0.23 | -1.39 | Upgrade
|
| EBITDA Margin | 20.28% | 14.78% | 12.24% | 2.46% | -19.51% | Upgrade
|
| D&A For EBITDA | 0.3 | 0.11 | 0.21 | 1.73 | 1.78 | Upgrade
|
| EBIT | 2.6 | 1.83 | 1.13 | -1.5 | -3.17 | Upgrade
|
| EBIT Margin | 18.18% | 13.96% | 10.30% | -16.02% | -44.56% | Upgrade
|
| Effective Tax Rate | 10.34% | 15.67% | 30.76% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.